title: The transcription factor GATA-6 regulates pathological cardiac hypertrophy.
abstract: BACKGROUND
  The transcriptional code that programs maladaptive cardiac hypertrophy involves the zinc finger-containing DNA binding factor GATA-4. The highly related transcription factor GATA-6 is also expressed in the adult heart, although its role in controlling the hypertrophic program is unknown.
  
  
  OBJECTIVE
  To determine the role of GATA-6 in cardiac hypertrophy and homeostasis.
  
  
  RESULTS
  Here, we performed a cardiomyocyte-specific conditional gene targeting approach for Gata6, as well as a transgenic approach to overexpress GATA-6 in the mouse heart. Deletion of Gata6-loxP with Nkx2.5-cre produced late embryonic lethality with heart defects, whereas deletion with β-myosin heavy chain-cre (βMHC-cre) produced viable adults with >95% loss of GATA-6 protein in the heart. These latter mice were subjected to pressure overload-induced hypertrophy for 2 and 6 weeks, which showed a significant reduction in cardiac hypertrophy similar to that observed Gata4 heart-specific deleted mice. Gata6-deleted mice subjected to pressure overload also developed heart failure, whereas control mice maintained proper cardiac function. Gata6-deleted mice also developed less cardiac hypertrophy following 2 weeks of angiotensin II/phenylephrine infusion. Controlled GATA-6 overexpression in the heart induced hypertrophy with aging and predisposed to greater hypertrophy with pressure overload stimulation. Combinatorial deletion of Gata4 and Gata6 from the adult heart resulted in dilated cardiomyopathy and lethality by 16 weeks of age. Mechanistically, deletion of Gata6 from the heart resulted in fundamental changes in the levels of key regulatory genes and myocyte differentiation-specific genes.
  
  
  CONCLUSIONS
  These results indicate that GATA-6 is both necessary and sufficient for regulating the cardiac hypertrophic response and differentiated gene expression, both alone and in coordination with GATA-4.
authors: Howard Hughes Medical Institute, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, Cincinnati, OH 45229-3039, USA.
authors: Jop H
authors: JH
authors: van Berlo
authors: John W
authors: JW
authors: Elrod
authors: Maarten M G
authors: MM
authors: van den Hoogenhof
authors: Allen J
authors: AJ
authors: York
authors: Bruce J
authors: BJ
authors: Aronow
authors: Stephen A
authors: SA
authors: Duncan
authors: Jeffery D
authors: JD
authors: Molkentin
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D006332:Cardiomegaly / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D002311:Cardiomyopathy, Dilated / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D002454:Cell Differentiation / Q000235:genetics; D050991:GATA4 Transcription Factor / Q000378:metabolism; D050993:GATA6 Transcription Factor / Q000235:genetics* / Q000378:metabolism; D017353:Gene Deletion; D006333:Heart Failure / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D006706:Homeostasis / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D014158:Transcription, Genetic / Q000502:physiology
chemical_list: D050991:GATA4 Transcription Factor; D050993:GATA6 Transcription Factor; C484171:Gata4 protein, mouse; C494760:Gata6 protein, mouse